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Letter to the Editor 
The first shortcoming of the interesting article by Manzano et al. refers to the missing 
ultrastructural investigation of the muscle biopsy [1]. In a recent study electron microscopy 
of a COVID-19 patient’s biopsy revealed degenerated cells with cytoplasmi
degenerated mitochondria, and cytoplasmic clusters of SARS
nerve-conduction studies and needle
recognised to complicate COVID
lesions do not rule out dermatomyositis, increasingly recognised as a feature of COVID
[4]. Since some of the drugs given to treat COVID
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c condensation, 
-CoV-2 particles [2]. Missing are 
-electromyography to rule out neuropathy, increasingly 
-19 [3], with secondary myopathic lesions. Absence of skin 
-19 are myotoxic (steroids, chloroquine, 
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azithromycin), muscle damage due to side effects of these drugs need to be excluded. 
Missing is the family history and the clinical neurologic exam to rule out a sub-clinically 
hereditary neuromuscular disorder, which became symptomatic through the infection. We 
should know the myoglobin levels and which drugs were given prior to admission for muscle 
weakness, myalgia, and fever to rule out rhabdomyolysis. The systemic inflammatory 
response, substantiated by elevated cytokine levels [5], should be excluded as the cause of 
the described cytopathy. 
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